Clinical Trial Update: Glenzocimab in Anterior Stroke With Large Ischemic Core Eligible for Endovascular Therapy [Phase 2, Phase 3]

View source ↗

Summary

This entry notes a Phase 2/3 clinical trial evaluating glenzocimab in patients with anterior stroke and a large ischemic core who are eligible for endovascular …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Glenzocimab (Glenzocimab)

Snippet

Sponsor: Fondation Ophtalmologique Adolphe de Rothschild | Conditions: Acute Ischemic Stroke | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING